Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-Current Deferred Tax Liability (2021 - 2022)

Historic Non-Current Deferred Tax Liability for Neuroone Medical Technologies (NMTC) over the last 2 years, with Q3 2022 value amounting to $140538.0.

  • Neuroone Medical Technologies' Non-Current Deferred Tax Liability rose 11894.41% to $140538.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $140538.0, marking a year-over-year increase of 11894.41%. This contributed to the annual value of $140538.0 for FY2022, which is 11894.41% up from last year.
  • Neuroone Medical Technologies' Non-Current Deferred Tax Liability amounted to $140538.0 in Q3 2022, which was up 11894.41% from $64189.0 recorded in Q3 2021.
  • Over the past 5 years, Neuroone Medical Technologies' Non-Current Deferred Tax Liability peaked at $140538.0 during Q3 2022, and registered a low of $64189.0 during Q3 2021.